# A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression

> **NCT00866593** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 260 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Generic Escitalopram
- **DRUG:** Innovator Escitalopram

## Key facts

- **NCT ID:** NCT00866593
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2013-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866593, "A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00866593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*